Newsletter

In the enclosed Newsletter you will find updated information about our operations and preparations for the next steps.

Qlife_pressmeddelande_19_10_16_0.pdf
2020-05-27
Status on Qlife’s COVID-19 tests

Qlife announced on 22 April that a research agreement had been made with Nordsjällands Hospital (NOH), for continued validation of the COVID-19 test.

2020-05-20
Bulletin from the Annual General Meeting in Qlife Holding AB on May 20th, 2020

Resolution on adoption of accounts and allocation of the company’s result

2020-05-20
Qlife Holding AB, Interim Report January – March 2020

FINANCIAL SUMMARY FIRST QUARTER 2020

2020-05-12
Qlife has entered a first strategically important sales agreement for their COVID-19 test

The parties have agreed a testing plan for all players, judges and club staff for Covid-19 in the professional leagues (3F SuperLiga and NordicBet Liga).

2020-04-22
Qlife enters agreement with Nordsjællands Hospital to start validation of COVID-19 test

Qlife announces that it has entered into a research agreement with Nordsjællands Hospital (NOH), to continue the validation of the Egoo Sars-CoV-2 virus test.

2020-04-16
Notice of annual shareholders’ meeting in Qlife Holding AB

Information regarding the coronavirus

2020-04-03
Qlife updates on process for COVID-19 test

Due to increased requests for information on route to market for Qlife’s COVID-19 test the company is updating the following:

2020-03-31
Qlife to expand the Egoo.Health platform with COVID-19 test through licence deal

Qlife announces that it has closed a license and supply agreement with Aidian Oy to access and incorporate their patented SIBA® Technology into the Egoo.Health platform.

2020-03-13
Corona virus, COVID-19, has limited impact on Qlife Holding AB

Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak.